SGI-DNA introduces BioXp system to give researchers priority access to personal DNA work station

NewsGuard 100/100 Score

SGI-DNA Inc. today announced the launch of the BioXp™ 3200 System Early Access Program giving researchers priority access to this one of a kind, personal DNA work station which delivers high quality synthetic DNA fragments. The BioXp™ Instrument has the capacity to simultaneously build 32 unique double-stranded DNA fragments. It is the first instrument system of its kind and empowers researchers with the ability to produce high quality synthetic DNA fragments virtually hands free.

Daniel Gibson, Ph.D., VP DNA Technology at Synthetic Genomics, Inc. states, "The vision is to evolve this system with greater capabilities by continuing to develop downstream applications for synthetic biology. Over time, the BioXp System will allow researchers to focus on experimental design instead of performing many of the tedious tasks of cloning and expression."

In addition to the opportunity to significantly advance their synthetic biology research, Early Access Program customers will enjoy exclusive perks such as an enhanced level of technical and customer support, including priority treatment of obtaining their constructs whether provided via BioXp™ DNA Assembly reagents or through SGI-DNA's custom synthesis service that excels in synthesizing long and difficult constructs.

The BioXp™ system utilizes the Gibson Assembly® technology and is coupled with a unique error correction formulation resulting in the synthesis of highly accurate DNA fragments. DNA fragments are ready for many applications including off-line sequencing, cloning, assembly into larger fragments, and expression into RNA and proteins. SGI-DNA's custom gene synthesis service option provides synthesis of longer and more challenging constructs for all gene synthesis needs for customers.

The Gibson Assembly® method was developed in 2009 by Daniel Gibson, Ph.D., and his colleagues at the J. Craig Venter Institute during the team's quest to construct the first synthetic cell. Since its introduction to the life science community, the Gibson Assembly® method has become a mainstay in many synthetic biology laboratories and has attracted interest from both the academic and commercial life sciences community due to its ease-of-use, robustness, and flexibility.

SOURCE SGI-DNA

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals e-cigarette users with limited smoking history show similar DNA alterations as smokers